Source comparison
Melanotan-2 vs Caffeine: Cardiovascular Effects Comparison
Peak Plasma Time 30–60 minutes post-injection 45–60 minutes post-ingestion Overlapping peaks if consumed simultaneously Timing separation eliminates peak overlap. Administer at least 2 hours apart Heart Rate Impact +8–12 bpm above baseline +5–8 bpm above basel
This comparison does not assign a generated winner or score.
- Peak Plasma Time
- 30–60 minutes post-injection
- 45–60 minutes post-ingestion
- Overlapping peaks if consumed simultaneously
- Timing separation eliminates peak overlap. Administer at least 2 hours apart
- Heart Rate Impact
- +8–12 bpm above baseline
- +5–8 bpm above baseline
- +12–18 bpm when peaks coincide
- Additive effect is predictable and dose-dependent. Not synergistic but cumulative
- Peripheral Vasoconstriction
- Moderate (MC4R-mediated)
- Moderate (adenosine antagonism)
- Enhanced constriction for 60–90 minutes
- Most pronounced in distal extremities and facial capillaries. Cosmetically noticeable
- Duration of Effect
- 4–6 hours (receptor binding)
- 5–6 hours (half-life dependent)
- Extended cardiovascular load
- Staggering administration by 2+ hours reduces cumulative cardiovascular strain
- Hypertensive Risk
- Minimal in normotensive individuals
- Minimal in habitual users
- Clinically insignificant unless baseline BP >130/85
- Pre-existing hypertension is the primary contraindication. Not the interaction itself